Hematological involvement in sarcoidosis: from cytopenias to lymphoma
- 2 November 2023
- journal article
- research article
- Published by Taylor & Francis in Expert Review of Clinical Immunology
- Vol. 20 (1) , 59-70
Abstract
We present an updated overview of the hematological involvementassociated with sarcoidosis, including a management approach forcytopenias and revisiting the association with hematologicalmalignancies. Theetiology of cytopenias in sarcoidosis can be attributed to two majoretiopathogenic mechanisms: infiltration of hematopoietic organs suchas the spleen and bone marrow, and autoimmune-mediated cytopenias.With respect to the association with hematological malignancies, itrequires careful evaluation of patients from a chronologicalperspective. Patients must be classified into one of three pathogenicscenarios, including preexisting hematological malignancies,synchronous development of malignancy and sarcoidosis due to commonpredisposing factors, or sarcoidosis as a predisposing factor formalignancies. The association between sarcoidosis and hematologic involvement isbest understood as a pathogenic continuum, with cytopenias andhematologic neoplasms intertwined due to various etiopathogenicmechanisms. These mechanisms include sarcoid infiltration ofhematopoietic organs, common predisposing immunogenetics for thedevelopment of autoimmune cytopenias and malignancies, and anincreased risk of neoplasm development in patients with autoimmunecytopenias. Collaboration among the main specialties involved in theclinical management of these patients is crucial for an earlymonitoring and management.Keywords
This publication has 87 references indexed in Scilit:
- Significant CD4, CD8, and CD19 Lymphopenia in Peripheral Blood of Sarcoidosis Patients Correlates with Severe Disease ManifestationsPLOS ONE, 2010
- Splenic sarcoidosis: An unusual aetiology of agranulocytosisAmerican Journal of Hematology, 2010
- Cancer risk in hospitalized sarcoidosis patients: a follow-up study in SwedenAnnals of Oncology, 2009
- Systemic sarcoidosis with bone marrow involvement responding to therapy with adalimumab: a case reportJournal of Medical Case Reports, 2009
- Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph ConsortiumBlood, 2008
- Autoimmunity and Susceptibility to Hodgkin Lymphoma: A Population-Based Case–Control Study in ScandinaviaJNCI: Journal of the National Cancer Institute, 2006
- Splenomegaly and splenectomy in sarcoidosis.Journal of Clinical Pathology, 1979
- Prognostic Significance of Lymphopenia in SarcoidosisActa Medica Scandinavica, 1979
- Pronounced Deficiency in T‐cells and Lymphocyte Chromosomal Aberrations in a Patient with Sarcoidosis, Myelofibrosis and Acute Leukaemia Following Thorotrast AngiographyActa Medica Scandinavica, 1977
- Etiology and therapy of thrombocytopenia associated with sarcoidosisThe Journal of Pediatrics, 1972